In addition, M2 TAMs have been reported to induce PD-L1 expression on tumor cells in non-small cell lung cancer (NSCLC) which prevents the activation of cytotoxic T cells (Sumitomo et al., 2019; Shima et al., 2020). The gene discussed is CD274; the disease is non-small cell lung carcinoma.